Is anti-Mullerian hormone a useful biomarker in the diagnosis of polycystic ovary syndrome in Chinese adolescents?

References

• Isabel-Bouzas IC, Cader SA, Leao L, et al. Menstrual cycle alterations during adolescence: early expression of metabolic syndrome and polycystic ovary syndrome. J Pediatr Adolescent Gynecol. 2014;27(6):335–341.
   PubMed Web of Science ®Google Scholar
• Ruan X, Li M, Mueck AO. Why polycystic ovary syndrome (PCOS) needs long-term management?. CPD. 2019;24(39):4685–4692.
   Google Scholar
• Rothenberg SS, Beverley R, Barnard E, et al. Polycystic ovary syndrome in adolescents. Best Pract Res Clin Obstet Gynaecol. 2018; 48:103–114.
   PubMed Web of Science ®Google Scholar
• Witchel SF, Burghard AC, Tao RH, et al. The diagnosis and treatment of PCOS in adolescents: an update. Curr Opin Pediatr. 2019;31(4):562–569.
   PubMed Web of Science ®Google Scholar
• Carmina E, Oberfield SE, Lobo RA. The diagnosis of polycystic ovary syndrome in adolescents. Am J Obstet Gynecol. 2010;203(3):201.e1–e5.
   Web of Science ®Google Scholar
• Darren JS, Howard CZ, Lois J. Screening for and treatment of polycystic ovary syndrome in teenagers. Exp Biol Med. 2004;229(5):369–369.
   Web of Science ®Google Scholar
• Park AS, Lawson MA, Chuan SS, et al. Serum anti-Mullerian hormone concentrations are elevated in oligomenorrheic girls without evidence of hyperandrogenism.. J Clin Endocrinol Metab. 2010;95(4):1786–1792.
   PubMed Web of Science ®Google Scholar
• Li H, Yan L, Lan L, et al. Role of baseline antral follicle count and anti-Mullerian hormone in prediction of cumulative live birth in the first in vitro fertilisation cycle: a retrospective cohort analysis. PLOS One. 2013;8(4):e61095.
   PubMed Web of Science ®Google Scholar
• Eilertsen TB, Vanky E, Carlsen SM. Anti-Mullerian hormone in the diagnosis of polycystic ovary syndrome: can morphologic description be replaced? Human Reprod. 2012;27(8):2494–2502.
   PubMed Web of Science ®Google Scholar
• Dewailly D, Gronier H, Poncelet E, et al. Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries. Hum Reprod. 2011;26(11):3123–3129.
   PubMed Web of Science ®Google Scholar
• Stamatina I, Kelsey TW, Anderson RA, et al. Can anti-Mullerian hormone predict the diagnosis of polycystic ovary syndrome? A systematic review and meta-analysis of extracted data. J Clin Endocrinol Metab. 2013;98(8):3332–3340.
   PubMed Web of Science ®Google Scholar
• Endocrinology group and guidelines expert group of the Chinese medical association obstetrics and gynecology branch. Guidelines for diagnosis and treatment of polycystic ovary syndrome in China. Chin J Obstet Gynecol. 2018;53:2–6.
   Google Scholar
• Rutjes AW, Reitsma JB, Vandenbroucke JP, et al. Case-control and two-gate designs in diagnostic accuracy studies. Clin Chem. 2005;51(8):1335–1341.
   PubMed Web of Science ®Google Scholar
• Kim JY, Tfayli H, Michaliszyn SF, et al. Anti-Müllerian hormone in obese adolescent girls with polycystic ovary syndrome. J Adolesc Health. 2017;60(3):333–339.
   PubMed Web of Science ®Google Scholar
• Yetim A, Yetim A, Ba F, et al. Anti-Müllerian hormone and inhibin-A, but not inhibin-B or insulin-like peptide-3, may be used as surrogates in the diagnosis of polycystic ovary syndrome in adolescents: preliminary results. Jcrpe. 2016;8(3):288–297.
   Google Scholar
• Tokmak A, Kokanali D, Timur H, et al. Association between anti-Mullerian hormone and insulin resistance in non-obese adolescent females with polycystic ovary syndrome. Gynecol Endocrinol. 2016;32(11):926–930.
   PubMed Web of Science ®Google Scholar
• Asanidze E, Kristesashvili J, Pkhaladze L, et al. The value of anti-Mullerian hormone in the management of polycystic ovary syndrome in adolescents. Gynecol Endocrinol. 2019;35(11):974– 974.
   PubMed Web of Science ®Google Scholar
• La Marca A, Pati M, Orvieto R, et al. Serum anti-Müllerian hormone levels in women with secondary amenorrhea. Fertil Steril. 2006;85(5):1547–1549.
   PubMed Web of Science ®Google Scholar
• Eldar-Geva T, Margalioth EJ, Gal M, et al. Serum anti-Mullerian hormone levels during controlled ovarian hyperstimulation in women with polycystic ovaries with and without hyperandrogenism. Hum Reprod. 2005;20(7):1814–1819.
   PubMed Web of Science ®Google Scholar
• La Marca A, Orvieto R, Giulini S, et al. Mullerian-inhibiting substance in women with polycystic ovary syndrome: relationship with hormonal and metabolic characteristics. Fertil Steril. 2004;82(4):970–972.
   PubMed Web of Science ®Google Scholar
• Pigny P, Merlen E, Robert Y, et al. Elevated serum level of anti-Mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest. J Clin Endocrinol Metab. 2003;88(12):5957–5962.
   PubMed Web of Science ®Google Scholar
• Durlinger ALL, Gruijters MJG, Kramer P, et al. Anti-Müllerian hormone inhibits initiation of primordial follicle growth in the mouse ovary. Endocrinology. 2002;143(3):1076–1084.
   PubMed Web of Science ®Google Scholar
• Tokmak A, Timur H, Aksoy RT, et al. Is anti-Mullerian hormone a good diagnostic marker for adolescent and young adult patients with polycystic ovary syndrome? Turk J Obstet Gynecol. 2015;12(4):199–204.
   PubMedGoogle Scholar
• Sopher AB, Grigoriev G, Laura D, et al. Anti-Mullerian hormone (AMH) may be a useful adjunct in the diagnosis of PCOS in adolescents. Pediatr Endocrinol Metab. 2014;27(0):1175–1179.
   PubMedGoogle Scholar
• Iwase A, Osuka S, Goto M, et al. Clinical application of serum anti-Müllerian hormone as an ovarian reserve marker: a review of recent studies: update on AMH. J Obstet Gynaecol Res. 2018;44(6):998–1006.
   PubMed Web of Science ®Google Scholar
• Linnet K, Bossuyt PM, Moons KG, et al. Quantifying the accuracy of a diagnostic test or marker. Clin Chem. 2012;58(9):1292–1301.
   PubMed Web of Science ®Google Scholar